Open-label pilot study of memantine in the treatment of compulsive buying

Department of Psychiatry, University of Minnesota, School of Medicine, Minneapolis, MN 55454, USA.
Annals of Clinical Psychiatry (Impact Factor: 2.36). 05/2012; 24(2):119-26.
Source: PubMed


Although compulsive buying (CB) is relatively common, pharmacotherapy research for CB is limited. Memantine, an N-methyl-D-aspartate receptor antagonist, appears to reduce glutamate excitability and improve impulsive behaviors, suggesting it may help individuals with CB.
Nine patients (8 females) with CB were enrolled in a 10-week open-label treatment study of memantine (dose ranging from 10 to 30 mg/d). Participants were enrolled from December 2008 until May 2010. The primary outcome measure was change from baseline to study endpoint on the Yale-Brown Obsessive Compulsive Scale-Shopping Version (Y-BOCS-SV).
Of the 9 participants, 8 (88.9%) completed the 10-week study. Y-BOCS-SV scores decreased from a mean of 22.0 ± 1.3 at baseline to 11.0 ± 5.3 at endpoint (P < .001). Hours spent shopping per week and money spent shopping both decreased significantly (P < .001). The mean effective dose of memantine was 23.4 ± 8.1 mg/d. Memantine treatment was associated with diminished impulsive buying and improvements on cognitive tasks of impulsivity. In addition, the medication was well-tolerated.
These findings suggest that pharmacologic manipulation of the glutamate system may target the impulsive behavior underlying CB. Placebo-controlled, double-blind studies are warranted in order to confirm these preliminary findings in a controlled design.

Download full-text


Available from: Brian Odlaug, Jul 30, 2015
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Compulsive shopping," a phrase often used to caricature women's spending or presumed preoccupation with material goods, has, within recent years, taken on a second meaning: that of a mental disorder, clinically referred to as "compulsive buying." Compulsive buying has not officially been defined as a "disorder," but it is being treated as such by psychiatrists and a growing segment of the general public. This emerging perception of compulsive buying as a mental disorder has only been possible because of larger cognitive and scientific shifts - one such shift being the preeminence now accorded to biological explanations for deviant behaviors. In the U.S., treating social problems as psychological problems, and psychological problems as biological problems, is, if not already the norm, quickly becoming so. The narrowing focus of critical and lay attention on individualized pathologies, particularly in the United States, has displaced broader social-structural analyses. My purpose in this paper, in attempt to offer a broader analysis, is to examine the disordering of compulsive buying, and discuss the role this disordering plays for American society.
    Full-text · Article ·
  • [Show abstract] [Hide abstract]
    ABSTRACT: Kleptomania is characterized by repetitive stealing behavior and has been associated with deleterious unwanted outcomes including forensic contact and increased rates of suicidal behavior. Very few trials have been conducted to investigate pharmacological treatment options for this neglected condition. Memantine is an NMDA-receptor antagonist that has shown promising results in the treatment of other behavioral addictions and substance addictions. Twelve individuals with kleptomania received memantine (10 mg/day, titrated to 30 mg/day maximum depending on clinical response and tolerability) over the course of 8 weeks, in an open-label trial. The effects of treatment were quantified using well-validated measures and select neurocognitive tests (last observation carried forward analyses). Kleptomania disease severity scores decreased across all measures considered, and 11 (91.7%) of the participants met the responder criteria (35% improvement on the primary effectiveness measure plus CGI improved/very much improved; significant improvements were also observed in terms of mood, anxiety, and disability scores along with a significant improvement in stop-signal response inhibition. Memantine was generally well tolerated. This study shows the effectiveness of memantine in reducing urges to shoplift and shoplifting behavior along with improving impulsivity, mood, anxiety, and psychosocial functioning.
    No preview · Article · Jan 2013 · International clinical psychopharmacology
  • [Show abstract] [Hide abstract]
    ABSTRACT: Behavioural addictions are characterized by an inability to resist an urge or drive resulting in actions that are harmful to oneself or others. Behavioural addictions share characteristics with substance and alcohol abuse, and in areas such as natural history, phenomenology, and adverse consequences. Behavioural addictions include pathological gambling, kleptomania, pyromania, compulsive buying, compulsive sexual behaviour, Internet addiction, and binge eating disorder. Few studies have examined the efficacy of pharmacological and psychological treatment for the various behavioural addictions, and therefore, currently, no treatment recommendations can be made.
    No preview · Article · May 2013 · Canadian journal of psychiatry. Revue canadienne de psychiatrie
Show more